Schizophrenia Bulletin

Aims & Scope

Schizophrenia Bulletin seeks to review recent developments and empirically based hypotheses regarding the etiology and treatment of schizophrenia.

We view the field as broad and deep, and will publish new knowledge ranging from the molecular basis to social and cultural factors.

We will give new emphasis to translational reports which simultaneously highlight basic neurobiological mechanisms and clinical manifestations.

Some of the Bulletin content is invited as special features or manuscripts organized as a theme by special guest editors.

Most pages of the Bulletin are devoted to unsolicited manuscripts of high quality that report original data or where we can provide a special venue for a major study or workshop report.

Supplement issues are sometimes provided for manuscripts reporting from a recent conference.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	4.8
2024	5.30

SJR (SCImago Journal Rank)

Year	Value
2024	2.138

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	228

Journal Rank

Year	Value
2024	1270

Journal Citation Indicator

Year	Value
2024	2693

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• PubMed
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia

  Citation: 17113

  Authors: S. R., A., L. A.

• Neurocognitive Deficits and Functional Outcome in Schizophrenia: Are We Measuring the "Right Stuff"?

  Citation: 2292

  Authors: M. F., R. S., D. L., J.

• The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway

  Citation: 2112

  Authors: O. D., S.

• Childhood Adversities Increase the Risk of Psychosis: A Meta-analysis of Patient-Control, Prospective- and Cross-sectional Cohort Studies

  Citation: 1955

  Authors: Filippo, Feikje, Marjan, Ritsaert, Tineke, Wolfgang, John, Jim, Richard P.

• The SPQ: A Scale for the Assessment of Schizotypal Personality Based on DSM-III-R Criteria

  Citation: 1677

  Authors: A.

• Prodromal Assessment With the Structured Interview for Prodromal Syndromes and the Scale of Prodromal Symptoms: Predictive Validity, Interrater Reliability, and Training to Reliability

  Citation: 1472

  Authors: T. J., T. H., J. L., K., J., W., D. O., G. D., S. W.

• The Quality of Life Scale: An Instrument for Rating the Schizophrenic Deficit Syndrome

  Citation: 1316

  Authors: D. W., T. E., W. T.

• Global Epidemiology and Burden of Schizophrenia: Findings From the Global Burden of Disease Study 2016

  Citation: 1216

  Authors: Fiona J, Alize J, Damian F, Sandra, Emily, James G, John J, Harvey A

• The NIMH-MATRICS Consensus Statement on Negative Symptoms

  Citation: 1050

  Authors: B., W. S, W. T, S. R

• Measurement of Premorbid Adjustment in Chronic Schizophrenia

  Citation: 980

  Authors: H. E., S. G., R. J.

---